https://doi.org/10.1097/01.sla.0000201480.65519.b8
X
Xiao-Jun Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
3.5K
Citations
16
h-index
18
i10-index
Xiao-Jun Lin is an academic researcher from BGI Group (China). The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies & Hepatitis C virus research. The author has an h-index of 16, co-authored 23 publications.
ORCID: 0000-0002-5015-330XPapers by this author
worksA Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma
2006 · Annals of Surgery · 1,426 citations
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
2012 · Journal of Clinical Oncology · 541 citations
https://doi.org/10.1200/jco.2012.42.9936
Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
2015 · BMC Cancer · 40 citations
https://doi.org/10.1186/s12885-015-1715-x
Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization
2015 · Chinese Journal of Cancer · 19 citations
https://doi.org/10.1186/s40880-015-0017-7
Epstein-Barr virus mRNA vaccine synergizes with NK cells to enhance nasopharyngeal carcinoma eradication in humanized mice
2025 · Molecular Therapy Oncology · 3 citations
https://doi.org/10.1016/j.omton.2025.200986
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat